Monthly Communication Reports in the last 6 Months for Innovative Medicines Canada / Médicaments novateurs Canada

Pamela Fralick, President (Organization)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-10 of 10


  1. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Marcel Saulnier, Associate ADM | House of Commons
    • Kendal Weber, Associate Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-01-29
    Posted date: 2020-02-14
    Communication number: 371-463180 View associated registration

  2. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-01-28
    Posted date: 2020-02-13
    Communication number: 371-464292 View associated registration

  3. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bill Morneau, Minister of Finance | Finance Canada (FIN)
    • Elder Marques, Chief of Staff to Minister Morneau | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2020-01-24
    Posted date: 2020-02-13
    Communication number: 371-464296 View associated registration

  4. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ryan Dunn, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, International Relations, Science and Technology
    Communication date: 2020-01-15
    Posted date: 2020-02-13
    Communication number: 371-464293 View associated registration

  5. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcel Saulnier, Associate ADM | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-01-09
    Posted date: 2020-02-14
    Communication number: 371-464429 View associated registration

  6. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-12-12
    Posted date: 2020-01-08
    Communication number: 371-462243 View associated registration

  7. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marilyn Gladu, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2019-12-12
    Posted date: 2020-01-08
    Communication number: 371-462242 View associated registration

  8. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Poilievre, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-11-28
    Posted date: 2020-01-08
    Communication number: 371-462239 View associated registration

  9. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2019-09-06
    Posted date: 2019-10-09
    Communication number: 371-459961 View associated registration

  10. Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Arif Virani, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-08-27
    Posted date: 2019-09-23
    Communication number: 371-459845 View associated registration


Return to Innovative Medicines Canada / Médicaments novateurs Canada